Indian pharma companies set to see 9-11% growth in FY25, says Icra
Indian pharmaceutical companies are set to experience 9-11 per cent revenue growth in FY25, driven by strong performances in key markets such as the United States, Europe, and emerging regions,…
Indian pharma industry headwinds in remission: ICRA
New Delhi: ICRA expects the revenues of the sample set of 25 Indian pharmaceutical companies (which account for ~60 per cent of the overall Indian pharmaceutical industry) to grow by 7-9 per…